SCHEMBL30825486

SCHEMBL30825486

CN1CCCC1COc1nc(N)c2cccc(F)c2n1

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.50
NOS1 P29475 1/20 0.50
NOS2 P35228 1/20 0.50
KRAS P01116 7/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29903142 0.80 KRAS (0.71) KRAS
SCHEMBL26724918 0.79 KRAS (0.68) KRAS
SCHEMBL29634820 0.77 KRAS (0.53) KRAS
SCHEMBL6017058 0.73 CHRNB4 (0.49)
SCHEMBL25779950 0.72 CHRNB1 (0.43) NOS3NOS1NOS2KRAS
SCHEMBL9245008 0.71 CHRNB4 (0.64)
SCHEMBL9245004 0.71 CHRNB4 (0.64)
SCHEMBL31423841 0.70 KRAS (0.48) NOS3NOS1NOS2KRAS
Hydrochloric Acid SCHEMBL9241700 0.70 CHRNB4 (0.63)
Hydrochloric Acid SCHEMBL9241706 0.70 CHRNB4 (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024063576-A1 NOVEL QUINAZOLINE COMPOUND AS KRAS INHIBITOR 일동제약(주) 2024-03-28 WO disclosed